HDA To Convene Rx Supply Chain Professionals as Industry Closes in on Drug Supply Chain Security Act Implementation Deadline

September 28, 2022

ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) will host its annual Traceability Seminar, providing an opportunity for supply chain professionals to discuss Drug Supply Chain Security Act (DSCSA) implementation.

Enacted in 2013, the DSCSA creates a nation-wide solution to trace products as they move through the pharmaceutical supply chain. By November 27, 2023, supply chain trading partners must provide serialized data in their transaction information along with product upon a change of ownership.

“Since the DSCSA was enacted nearly 10 years ago, HDA and our distributor members have been at the center of industry implementation — providing timely and high-quality education is a core part of those efforts,” said Perry Fri, Executive Vice President, Industry Relations, Membership and Education, HDA and Chief Operating Officer, HDA Research Foundation. “As trading partners face their final year to establish an interoperable framework, HDA is pleased to be back in person for 2022, bringing stakeholders together from across the supply chain to connect directly with traceability experts.”

The seminar, to be held on October 12–14 at the Marriott Marquis in Washington, D.C., will feature opportunities for industry stakeholders to share best practices, strategize solutions and help finalize 2023 plans. Connie Jung, RPh, Senior Advisor for Policy, U.S. Food and Drug Administration (FDA), will provide updates on the agency’s recent activities and DSCSA milestones and clarify FDA’s expectations of the pharmaceutical distribution industry. A panel of pharmacy experts will discuss their unique challenges and strategies for planning for 2023. Additional sessions will cover gaps in product tracing, key implementation impediments and onboarding progress.

HDA will also present the latest results of the HDA Research Foundation’s Serialization Readiness Survey, which analyzes the current readiness of manufacturers and distributors to meet DSCSA requirements. With FDA formally endorsing the GS1 US Electronic Product Code Information Services (EPCIS) standard for data exchange, HDA will share an update on the industry’s progress toward its adoption.

View the full agenda, registration information and participating sponsors on HDA’s website. Complimentary registration is available for media.

About HDA

The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s nonprofit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.